Sumitoma Pharma US
Kerri Ellis is an experienced professional in the field of manufacturing, currently serving as the cGMP Manufacturing Manager at Sumitomo Pharma America, Inc. since August 2025. Prior to this role, Kerri held various positions at Adaptimmune from April 2020 to August 2025, including Manufacturing Manager, Manufacturing Supervisor, Lead Manufacturing Cell Therapy Specialist, and Manufacturing Cell Therapy Specialist. Kerri began a career in biopharmaceuticals at WuXi AppTec as a Biopharmaceutical Manufacturing Associate, specializing in Viral Vector Manufacturing, from May 2019 to April 2020. Kerri holds a Bachelor of Science degree in Biology from Temple University, earned between 2015 and 2018.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.